1401/2682US=47 / Câncer
Klein C, Vassilev LT. Targeting the p53/MDM2 pathway for cancer therapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 19-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

SEGMENTACAO DA VIA P53/MDM2; TERAPIA DE CANCER; PROTEINA P53; MDM2; SUPRESSOR DE TUMOR; INTERACAO PROTEINA-PROTEINA; INTERACAO P53-MDM2


1402/2682US=47 / Câncer
Bender RP, Osheroff N. DNA topoisomerases as targets for the chemotherapeutic treatment of cancer. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 57-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

TOPOISOMERASES DE DNA; CANCER. TERAPIA; QUIMIOTERAPIA; TOPOISOMERASE II; TOPOISOMERASE IIALFA; TOPOISOMERASE IIBETA; TOPOISOMERASE II POISONS; FARMACOS ANTICANCERIGENOS; GENOTOXICIDADE; LEUCEMIA; DNA SUPERCOILING; LESAO DNA


1403/2682US=47 / Câncer
Kawabe T. Compounds that abrogate the G2 checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 117-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

CICLO CELULAR; G1; G2; ONCOGENESE; TERAPIA DO CANCER; DANOS AO DNA; REPARO DO DNA; MUTACAO


1404/2682US=44 / Gastro
Fong Y. Metastatic liver cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 469-97. ISBN 978-1-4051-2783-7.

CANCER HEPATICO METASTATICO. TRATAMENTO; CANCER HEPATICO METASTATICO. QUIMIOTERAPIA SISTEMICA; CANCER HEPATICO METASTATICO. TERAPIA ABLATIVA; CANCER HEPATICO METASTATICO. RADIOTERAPIA


1405/2682US=49-C / Câncer
Wierstra I, Alves J. The c-myc promoter: still myster Y and challenge. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2008. p. 113-333. ISBN 978-0-12-3742247.

PROMOTOR C-MYC; C-MYC. FUNCAO; C-MYC. BIOLOGIA; C-MYC. EXPRESSAO; C-MYC. REGULACAO; C-MYC. ESTRUTURA; C-MYC. TRANSCRICAO; ESTRUTURA DA CROMATINA; C-MYC. AUTOSUPRESSAO; C-MYC. FATORES DE TRANSCRICAO; TRANSDUCAO DE VIAS DE SINALIZACAO; TERAPIA ANTICANCER


1406/2682US=49-D / Câncer
Wagh PK, Peace BE, Waltz SE. Met-related receptor tyrosine kinase ron in tumor growth and metastasis. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 1-33. ISBN 978-0-12-374358-9.

RECEPTOR MET; TIROSINA-QUINASE; CRESCIMENTO TUMORAL; METASTASE; CANCER; RON. ESTRUTURA; RON. FUNCAO; RON (REGIAO ORGANIZADORA DE NUCLEOLO); MACROFAGOS; TRANSICAO EPITELIAL MESENQUIMAL; TUMORIGENESE; ANGIOGENESE; EXPRESSAO EM TUMORES HUMANOS; CANCER DE MAMA; CANCER DE PROSTATA; CANCER DE PANCREAS; CANCER DE RIM; CANCER DE BEXIGA; CANCER DE OVARIO; CANCER DE PULMAO; CANCER GASTROINTESTINAL; CANCER DE FIGADO; CANCER. TERAPIA


1407/2682US=49-D / Câncer
Cao Y. Molecular mechanisms and therapeutic development of angiogeneseis inhibitors. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 113-31. ISBN 978-0-12-374358-9.

INIBIDORES DA ANGIOGENESE; MECANISMOS MOLECULARES; DESENVOLVIMENTO TERAPEUTICO; FATORES ANGIOGENICOS TUMORAIS; VASOS SANGUINEOS; ALVOS TERAPEUTICOS; RESISTENCIA A DROGAS; MECANISMOS DE INIBIDORES; TERAPIA ANTIANGIOGENICA; QUIMIOTERAPIA; BIOMARCADORES


1408/2682US=34 / Imagem
Tartar M, Comstock CE, Kipper MS. Radiation therapy effects and considerations. In: ___. Breast cancer imaging: a multidisciplinary, multimodality approach. Philadelphia: Mosby Elsevier, 2008. p. 570-604. ISBN 978-0-323-04677-0.

CANCER DE MAMA; RADIOTERAPIA; TERAPIA DE RADIACAO; ESTUDO DE CASO


1409/2682US=59 / Cab/Pesc
Delaere PR. Surgery of the orocervical region. In: Hermans R. Squamous cell cancer of the neck. New York: Cambridge University Press, 2008. p. 35-47. (Contemporary Isues in Cancer imaging) ISBN 978-0-521-88691-8.

CANCER DE CABECA E PESCOCO; CARCINOMA DE CELULAS ESCAMOSAS; REGIAO OROCERVICAL. CIRURGIA; METASTASE CERVICAL. TERAPIA; CANCER DA CAVIDADE ORAL; CANCER OROFARINGEO; CANCER DE LARINGE; CANCER DE HIPOFARINGE; CANCER DE ESOFAGO CERVICAL


1410/2682US=60 / Enfermagem
Hoffman C. Complementary and alternative therapies in cancer care. In: Corner J, Bailey C. Cancer nursing: care in context. 2nd ed. St. Louis: Blackwell Science, 2008. p. 394-426. ISBN 978-1-4051-2253-5.

CANCER. TRATAMENTO; TERAPIA COMPLEMENTAR; TERAPIA ALTERNATIVA


1411/2682US=44 / Gastro
Das A, Chak A. Esophageal adenocarcinoma: treatment. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 51. ISBN 978-1-4051-2783-7.

ESOFAGO DE BARRETT. TERAPIA


1412/2682US=63 / Enfermagem
Sorrentino SA. Nutrition support and IV therapy. In: ___. Mosby's textbook for nursing assistants. 7th ed. St. Louis: Elsevier Mosby, 2008. p. 427-38. ISBN 978-0-323-04994-8.

SUPORTE NUTRICIONAL; TERAPIA INTRAVENOSA; NUTRICAO ENTERAL; NUTRICAO PARENTERAL


1413/2682US=63 / Enfermagem
Sorrentino SA. Respiratory support and therapies. In: ___. Mosby's textbook for nursing assistants. 7th ed. St. Louis: Elsevier Mosby, 2008. p. 598-605. ISBN 978-0-323-04994-8.

SUPORTE RESPIRATORIO; TERAPIA RESPIRATORIA; VIAS AEREAS ARTIFICIAIS; INTUBACAO; TRAQUEOSTOMIA; SUCCAO; VENTILACAO MECANICA; DRENOS TORACICOS


1414/2682US=64 / Câncer
Heffner LT. Staging in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 3-7. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

MIELOMA MULTIPLO; TERAPIA-ALVO; MEDICINA TRADUCAO; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR


1415/2682US=64 / Câncer
Harousseau JL. Role of autologous stem cell transplantation in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 79-90. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TRANSPLANTE AUTOLOGO DE CELULAS-TRONCO NO MIELOMA MULTIPLO; TERAPIA DE ALTA DOSE; HDT; AUTOLOGO TRANSPLANTE DE CELULAS ESTAMINAIS


1416/2682US=64 / Câncer
Kaufman JL, Mihelic R, Lonial S. Maintenance therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 91-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TERAPIA DE MANUTENCAO NO MIELOMA MULTIPLO


1417/2682US=64 / Câncer
Sara B, Antonio P. Therapy for patients not eligible for autologous transplant. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 99-112. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TERAPIA PARA PACIENTES NAO COMPATIVEL TRANSPLANTE; TRANSPLANTE AUTOLOGO; QUIMIOTERAPIA CONVENCIONAL


1418/2682US=64 / Câncer
Buadi FK, Rajkumar SV. Thalidomide: induction therapy. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 229-37. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TALIDOMIDA; TERAPIA DE INDUCAO; MIELOMA MULTIPLO; CLONAL DE CELULAS ESTAMINAIS


1419/2682US=64 / Câncer
San MFJ, Mateos MV. Bortezomib as induction therapy in patients with multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 253-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BORTEZOMIB; PACIENTES COM MIELOMA MULTIPLO. TERAPIA DE INDUCAO


1420/2682US=64 / Câncer
Kumar S. Lenalidomide for initial therapy of newly diagnosed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 279-88. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

LENALIDOMIDA. TERAPIA COM MIELOMA MULTIPLO; MALIGNIDADE HEMATOLOGICA. LINFOMA NAO-HODGKIN


Primeira | Anterior | Próxima | Última